EP 0648119 A1 19950419 - 5'-INDOLINYL OXAZOLIDINONES USEFUL AGAINST -i(MYCOBACTERIUM TUBERCULOSIS).
Title (en)
5'-INDOLINYL OXAZOLIDINONES USEFUL AGAINST -i(MYCOBACTERIUM TUBERCULOSIS).
Title (de)
GEGEN MYCOBACTERIUM TUBERCULOSIS VERWENDBARE 5'-INDOLINYLOXAZOLIDINONE.
Title (fr)
UTILISATION DE 5'-INDOLINYLOXAZOLIDINONES CONTRE LE -i(MYCOBACTERIUM TUBERCULOSIS).
Publication
Application
Priority
- US 9304850 W 19930526
- US 90938792 A 19920708
Abstract (en)
[origin: WO9401110A1] 5-(S)-N-(1'-Hydroxyacetyl-5'-indolinyl)-5-(acetamidomethyl)-2-oxazolidinone and 5-(S)-N-(1'-(2-thiophenecarbonyl)-5'-indolinyl)-5-(acetamidomethyl)-2-oxazolidinone are useful in treating tuberculosis caused by (M. Tuberculosis).
[origin: WO9401110A1] 5-(S)-N-(1'-Hydroxyacetyl-5'-indolinyl)-5-(acetamidomethyl)-2-oxazolid inone and 5-(S)-N-(1'-(2-thiophenecarbonyl)-5'-indolinyl)-5-(acetamidomethyl)-2- oxazolidinone are useful in treating tuberculosis caused by M. Tuberculosis.
IPC 1-7
IPC 8 full level
A61K 31/42 (2006.01); A61P 31/04 (2006.01); A61P 31/06 (2006.01); C07D 413/04 (2006.01)
CPC (source: EP KR)
A61K 31/42 (2013.01 - EP KR); A61P 31/04 (2017.12 - EP); A61P 31/06 (2017.12 - EP)
Citation (search report)
See references of WO 9401110A1
Designated contracting state (EPC)
AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE
DOCDB simple family (publication)
WO 9401110 A1 19940120; AU 4386593 A 19940131; AU 666740 B2 19960222; CA 2136324 A1 19940120; EP 0648119 A1 19950419; IL 106220 A0 19931115; JP H07508985 A 19951005; KR 950702417 A 19950729; MX 9303764 A 19940131; TW 260608 B 19951021
DOCDB simple family (application)
US 9304850 W 19930526; AU 4386593 A 19930526; CA 2136324 A 19930526; EP 93914058 A 19930526; IL 10622093 A 19930702; JP 50329494 A 19930526; KR 19950700069 A 19950107; MX 9303764 A 19930623; TW 82104539 A 19930608